Lab
Shiel Medical Laboratory, INC
Shiel Medical Laboratory, INC was paid $33K by Medicaid between Apr 2018 and Jun 2018, across 46 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 29% of everything it billed.
33Billing provider infoSHIEL MEDICAL LABORATORY, INC
BROOKLYN, NY 11205
BROOKLYN, NY 11205
33aNPI1750374088assigned 08/23/2005
33bProvider typeClinical Medical Laboratory
28Total paid$33K
24GClaims2,938
24DCodes billed46
24AFirst – last monthApr 2018 – Jun 2018
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#94 of 116
Median peer was paid$618K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,938 | $33K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 29% | 290 | 172 | $9K |
| 80050 | General health panel | 8.5% | 132 | 131 | $3K |
| 86480 | 8.4% | 80 | 80 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.7% | 97 | 97 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.6% | 96 | 96 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.9% | 78 | 77 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3.3% | 246 | 244 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.2% | 246 | 242 | $1K |
| 80061 | Lipid panel | 2.6% | 119 | 118 | $870.48 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.0% | 50 | 50 | $669.00 |
| 84144 | 1.8% | 52 | 37 | $602.68 | |
| 86762 | 1.6% | 64 | 64 | $512.00 |
34 more codes
| 80053 | Comprehensive metabolic panel | 1.6% | 87 | $510.69 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 16 | $505.44 |
| 87081 | 1.5% | 137 | $504.16 | |
| 86747 | 1.5% | 59 | $492.65 | |
| 82607 | 1.2% | 48 | $393.39 | |
| 86735 | 1.2% | 53 | $384.25 | |
| 86765 | 1.2% | 53 | $379.48 | |
| 81001 | 1.1% | 216 | $374.88 | |
| 82670 | 1.1% | 24 | $372.48 | |
| 83655 | 1.1% | 54 | $363.42 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 62 | $324.00 |
| 84439 | <1% | 64 | $320.64 | |
| 87088 | <1% | 67 | $303.79 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 16 | $235.52 |
| 82746 | <1% | 28 | $228.76 | |
| 83002 | <1% | 22 | $226.38 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 22 | $205.48 |
| 83001 | <1% | 19 | $196.08 | |
| 84480 | <1% | 23 | $181.24 | |
| 82728 | <1% | 23 | $174.11 | |
| 87186 | <1% | 31 | $148.80 | |
| 87510 | <1% | 14 | $144.82 | |
| 87480 | <1% | 14 | $144.82 | |
| 87660 | <1% | 14 | $144.82 | |
| 87077 | <1% | 30 | $135.43 | |
| 82950 | <1% | 49 | $129.36 | |
| 84146 | <1% | 12 | $129.12 | |
| 87147 | <1% | 38 | $109.44 | |
| 84702 | <1% | 13 | $108.81 | |
| 83550 | <1% | 14 | $68.04 | |
| 83540 | <1% | 18 | $64.80 | |
| 84550 | <1% | 23 | $57.73 | |
| 82550 | <1% | 13 | $47.06 | |
| 85652 | <1% | 12 | $18.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOHN, GITTY (ADMINISTRATIVE DIRECTOR)